Nephros
NEPHNephros is a commercial-stage medical technology company that develops and markets high-performance water filtration solutions designed to prevent infection and ensure water purity.
Earnings
Next report
Nov 5, 2026 (in 2 months)Competitors
By market cap
By revenue growth
Profile
Nephros is a commercial-stage medical technology company that develops and markets high-performance water filtration solutions designed to prevent infection and ensure water purity. The company specializes in medical-grade ultrafiltration and microfiltration technologies that physically remove bacteria, viruses, and endotoxins from water systems. Its core value proposition centers on providing FDA 510(k)-cleared solutions for critical-use environments where water quality is essential to patient safety and operational compliance.
Nephros distinguishes itself through FDA 510(k)-cleared medical-grade validation and superior membrane surface area that offers longer service life than many competitors.
FAQ
- What is Nephros's market cap?
- Nephros (NEPH) has a market capitalization of $46.6M and trades on NASDAQ.
- Who are Nephros's competitors?
- Nephros's key competitors include Pentair, Cytiva, 3M Company, and others. These companies compete in similar markets and product categories.
- Who does Nephros partner with?
- Nephros's notable partners include Medica S.p.A., Donastar LLC.
- Where is Nephros headquartered?
- Nephros is headquartered in United States of America and employs approximately 31 people. It has been publicly traded since 2004.